SynerFuse

The Health 2.0 Conference is a premier international event that brings together distinguished experts from various healthcare specialties to reimagine and innovate the healthcare landscape. The conference serves as a vibrant platform to spotlight the latest developments in healthcare and wellness, fostering networking and the exchange of ideas among forward-thinking individuals and organizations. This year, the conference took place March 4-6 in Las Vegas. SynerFuse? President, CEO, & Co-Founder Justin Zenanko served as the keynote speaker at the conference with a presentation titled "Leadership + Capital + Execution = Innovation." Zenanko and Chief Medical Officer Rohan Lall, M.D., both also participated in several panel discussions, interviews, and presentations at the conference. #neuromodulation #spinalfusion #painmanagement #opioidcrisis #chronicpain #neurostimulation #medicaldevices #medtech #medicaldevice #healthcare #health #researchandinnovation #research #innovation #backpain Steven Falowski - Chris Frank - David Miel - Brooke Campbell - Nameer Haider - Thomas S., Schreier, Jr. - Dennis McFadden - Barbara S. - Jeff Erb

The following contains information regarding an investigational product, the safety or effectiveness of which has not been established. This investigational product is not approved by the FDA and is currently being studied under an FDA-approved Investigational Device Exemption study. The product is limited by Federal (U.S.) law to investigational use only. SynerFuse? makes no claims of safety or effectiveness of the investigational product, and the intent of presenting this information is to convey research and development initiatives underway at SynerFuse?. ICYMI: 5 Medtech Notes in Becker's Spine Review Include SynerFuse, https://lnkd.in/ge2impJs #neuromodulation #spinalfusion #painmanagement #opioidcrisis #chronicpain #neurostimulation #medicaldevices #medtech #medicaldevice #healthcare #health #researchandinnovation #research #innovation #backpain Becker's Healthcare - Justin Zenanko - Rohan Lall - Steven Falowski - Chris Frank - David Miel - Brooke Campbell - Nameer Haider - Thomas S., Schreier, Jr. - Dennis McFadden - Barbara S. - Jeff Erb

Join us at #CXO2Conf for a thought-provoking panel discussion on "Taking a Public Stand on Social Issues: Key Factors for Companies to Consider." Industry leaders will explore the risks, rewards, and responsibilities of corporate activism in today’s dynamic landscape. Panelists: Justin Zenanko, Candice Mason, Biplab Malo #panel #paneldiscussion #cxo #ceo #lasvegasconference #lasvegas #usa #cxo2conf

The following contains information regarding an investigational product, the safety or effectiveness of which has not been established. This investigational product is not approved by the FDA and is currently being studied under an FDA-approved Investigational Device Exemption study. The product is limited by Federal (U.S.) law to investigational use only. SynerFuse? makes no claims of safety or effectiveness of the investigational product, and the intent of presenting this information is to convey research and development initiatives underway at SynerFuse?. SynerFuse? appeared in Becker's Spine Review today: SynerFuse, in partnership with the Minneapolis-based University of Minnesota, South Bend Orthopaedics (Ind.) and RQM+, has completed the first proof-of-concept study of its electric transforaminal lumbar interbody fusion procedure... Read the full Becker's Healthcare story here: https://lnkd.in/gtmF9JJU Justin Zenanko Rohan Lall Steven Falowski - Chris Frank - David Miel - Brooke Campbell - Nameer Haider - Thomas S., Schreier, Jr. - Dennis McFadden - Barbara S. - Jeff Erb

Justin Zenanko from SynerFuse joined top leaders and key stakeholders to explore cutting-edge investment strategies and the latest publicly registered offerings as a sponsor af the Institute for Portfolio Alternatives 2024 IPAConnect Registered Funds conference held in Orlando, Florida, December 9-11. The conference featured dynamic discussions on strategies such as Interval Funds, Private Credit, BDCs, Private Real Estate, REITs, Private Equity, and more. #neuromodulation #spinalfusion #painmanagement #opioidcrisis #chronicpain #neurostimulation #medicaldevices #medtech #medicaldevice #healthcare #health #researchandinnovation #research #innovation #backpain Steven Falowski - Chris Frank - David Miel - Brooke Campbell - Nameer Haider - Thomas S., Schreier, Jr. - Dennis McFadden - Barbara S. - Jeff Erb

The National Due Diligence Alliance (TNDDA) provides a forum for independent broker/dealers, family offices, and advisors, product and service sponsors, law firms, and analysts to facilitate the due diligence process for the benefit of the investing public. Chief Medical Officer Dr. Rohan Lall and CEO Justin Zenanko gave a 25-minute presentation on SynerFuse at the Alliance's conference, held in Houston, Texas, November 22-24, and had conversations with attendees who visited the company’s exhibit booth. #neuromodulation #spinalfusion #painmanagement #opioidcrisis #chronicpain #neurostimulation #medicaldevices #medtech #medicaldevice #healthcare #health #researchandinnovation #research #innovation #backpain Steven Falowski - Chris Frank - David Miel - Brooke Campbell - Nameer Haider - Thomas S., Schreier, Jr. - Dennis McFadden - Barbara S. - Jeff Erb

The following contains information regarding an investigational product, the safety or effectiveness of which has not been established. This investigational product is not approved by the FDA and is currently being studied under an FDA-approved Investigational Device Exemption study. The product is limited by Federal (U.S.) law to investigational use only. SynerFuse? makes no claims of safety or effectiveness of the investigational product, and the intent of presenting this information is to convey research and development initiatives underway at SynerFuse?. Check out Episode 280 of The Back Doctors podcast in which host Dr. Michael Johnson and SynerFuse? President & CEO Justin Zenanko discuss our patented Electric Transforaminal Lumbar Interbody Fusion (e-TLIF?), https://lnkd.in/g9WqUJj7 #neuromodulation #spinalfusion #painmanagement #opioidcrisis #chronicpain #neurostimulation #medicaldevices #medtech #medicaldevice #healthcare #health #researchandinnovation #research #innovation #backpain Steven Falowski - Rohan Lall - Chris Frank - David Miel - Brooke Campbell - Nameer Haider - Thomas S., Schreier, Jr. - Dennis McFadden - Barbara S. - Jeff Erb

Now presenting at #InnovationSanDiego is SynerFuse with CEO & Co-founder Justin Zenanko. The patented SynerFuse? (Eden Prairie, Minnesota, USA) procedure, Electric Transforaminal Lumbar Interbody Fusion (e-TLIF?), combines fusion with direct nerve stimulation to address chronic low back and leg pain that is unaddressed in traditional spinal fusion surgery. The aims of SynerFuse is to decrease number of back fusions/surgeries related to pain and address chronic pain at the point of surgery. Remain informed on new articles, conference updates and more with our helpful #medtech community newsletter. Subscribe here: https://bit.ly/42KHJKI

ICYMI: Check out this recent Bionics Institute podcast featuring SynerFuse CEO Justin Zenanko...

The following contains information regarding an investigational product, the safety or effectiveness of which has not been established. This investigational product is not approved by the FDA and is currently being studied under an FDA-approved Investigational Device Exemption study. The product is limited by Federal (U.S.) law to investigational use only. SynerFuse? makes no claims of safety or effectiveness of the investigational product, and the intent of presenting this information is to convey research and development initiatives underway at SynerFuse?. Check out this new Bionics Institute Med Tech Talks podcast episode in which Robert Klupacs is joined by Justin Zenanko, co-founder, CEO and president of SynerFuse?. In this episode you will hear about: -The global need to address opioid dependency by developing innovative drug-free treatments for chronic pain -How the SynerFuse e-TLIF technology stimulates the dorsal root ganglion as part of spinal fusion surgery – a world-first approach -How Justin and his co-founders overcame skepticism from specialists and the challenges of the COVID pandemic to get FDA approval on a feasibility study -Why Justin has invested his own money into SynerFuse and his advice to other unconventional entrepreneurs. Listen here: https://lnkd.in/gZpJxsFj #MedTech #HealthcareInnovation #ChronicPain #OpioidCrisis #Neuromodulation #PainManagement #SpinalFusion #Entrepreneur #BackPain